Blog Archives

PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models

October 10, 2016
Flow CAST® – Kinase Inhibtion Assay Citation: Winkler, DG et al. PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chem Biol. 2013 Nov 21;20(11):1364-74. doi: 10.1016/j.chembiol.2013.09.017. Epub 2013 Nov 7. PMID: 24211136. "These studies demonstrate that IPI-145 exerts profound effects on adaptive and innate immunity by inhibiting
Continue Reading →

Proactive Therapeutic Drug Monitoring of Infliximab: A Comparative Study of a New Point-of-Care Quantitative Test with Two Established ELISA Assays

October 5, 2016
BÜHLMANN Quantum Blue® Infliximab Trough Level Assay Citation: Afonso J, Lopes S et al. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays. Aliment Pharmacol Ther. 2016 Oct;44(7):684-92. doi: 10.1111/apt.13757. Epub 2016 Aug 10. PMID: 27507790 First Publication using our Quantum Blue® Infliximab Trough Level Assay We are very
Continue Reading →
Exhibition Booth

Visit us at UEGW2016

October 5, 2016

BÜHLMANN will be present from October 15th to 19th at the 2016 United European Gastro Week Visit us at booth #31 in Hall X2 Exhibtion Highlights: Presentation of the first Infliximab Therapeutic Drug Montioring Point-of-Care Rapid Test Presentation of the first truly random access BÜHLMANN fCAL turbo assay Oral Presentation #OP247: 18 months market experience

Continue Reading →

First Publication using our Quantum Blue® Infliximab Trough Level Assay

October 5, 2016

We are very pleased to announce the publication of the first article describing our Quantum Blue® Infliximab trough level assay. The authors around Professor F. Magro claim that: “On the basis of this study, we may conclude that the point-of-care Quantum Blue is a reliable alternative to the time-consuming ELISAs, allowing the fast and accurate assessment of

Continue Reading →